Pictet Asset Management
MIRM icon

Pictet Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Pictet Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.6M Buy
526,443
+102,932
+24% +$10.3M 0.06% 298
2026
Q1 		$39.1M Sell
423,511
-153,763
-27% -$14.5M 0.04% 361
2025
Q4 		$45.6M Buy
577,274
+35,997
+7% +$2.58M 0.04% 346
2025
Q3 		$39.7M Sell
541,277
-159,879
-23% -$10.2M 0.04% 366
2025
Q2 		$35.7M Sell
701,156
-77,088
-10% -$3.43M 0.04% 378
2025
Q1 		$35.1M Sell
778,244
-81,852
-10% -$3.86M 0.04% 374
2024
Q4 		$35.6M Sell
860,096
-35,594
-4% -$1.48M 0.04% 368
2024
Q3 		$34.9M Buy
895,690
+20,577
+2% +$821K 0.04% 362
2024
Q2 		$29.9M Sell
875,113
-80,801
-8% -$2.12M 0.03% 374
2024
Q1 		$24M Buy
955,914
+162,259
+20% +$4.46M 0.03% 459
2023
Q4 		$23.4M Buy
793,655
+54,645
+7% +$1.65M 0.03% 447
2023
Q3 		$23.4M Buy
+739,010
New +$20.2M 0.03% 418

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management's MIRM Position: Q2 2026 in Review

Pictet Asset Management increased its Mirum Pharmaceuticals (MIRM) stake by 24% in Q2 2026, buying an estimated $10.3M and bringing the position to 526,443 shares worth $61.6M. The position accounts for 0.06% of the portfolio, ranked #298.

Pictet Asset Management first reported a position in MIRM in Q3 2023 and has held it in 12 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Pictet Asset Management held 526,443 shares of Mirum Pharmaceuticals worth $61.6M as of Q2 2026.
  • Pictet Asset Management bought 102,932 Mirum Pharmaceuticals shares in Q2 2026, an estimated $10.3M.
  • Mirum Pharmaceuticals made up 0.06% of Pictet Asset Management's portfolio in Q2 2026, its #298 holding.
  • Pictet Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.